Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001369:Axons / Q000293:injuries; D001562:Benzimidazoles / Q000494:pharmacology; D001835:Body Weight; D001921:Brain / Q000503:physiopathology*; D001930:Brain Injuries; D001931:Brain Mapping; D002375:Catalepsy; D002552:Cerebral Ventricles / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology* / Q000502:physiology; D001068:Feeding and Eating Disorders; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D008297:Male; D001523:Mental Disorders; D008856:Microscopy, Fluorescence; D009410:Nerve Degeneration; D011187:Posture; D051381:Rats; D013238:Stereotaxic Techniques; D013268:Stimulation, Chemical; D013378:Substantia Nigra / Q000187:drug effects; D009435:Synaptic Transmission; D013894:Thirst
D001562:Benzimidazoles; D001058:Apomorphine; D004298:Dopamine